Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression
Ricardo Alexandre Toniolo, Michelle Silva, Francy de Brito Ferreira Fernandes, et al.
Journal of Neural Transmission (2017) Vol. 125, Iss. 2, pp. 247-257
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Creatine in Health and Disease
Richard B. Kreider, Jeffrey R. Stout
Nutrients (2021) Vol. 13, Iss. 2, pp. 447-447
Open Access | Times Cited: 126
Effects of Creatine Supplementation on Brain Function and Health
Scott C. Forbes, Dean M. Cordingley, Stephen M. Cornish, et al.
Nutrients (2022) Vol. 14, Iss. 5, pp. 921-921
Open Access | Times Cited: 78
Nutraceuticals in Psychiatric Disorders: A Systematic Review
Paola Bozzatello, Roberta Novelli, Cristiana Montemagni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4824-4824
Open Access | Times Cited: 8
Beyond sports: Efficacy and safety of creatine supplementation in pathological or paraphysiological conditions of brain and muscle
Maurizio Balestrino, Enrico Adriano
Medicinal Research Reviews (2019) Vol. 39, Iss. 6, pp. 2427-2459
Closed Access | Times Cited: 69
Creatine for the Treatment of Depression
Brent M. Kious, Douglas G. Kondo, Perry F. Renshaw
Biomolecules (2019) Vol. 9, Iss. 9, pp. 406-406
Open Access | Times Cited: 55
Mitochondrial dysfunction as a critical event in the pathophysiology of bipolar disorder
Giselli Scaini, Taylor Andrews, Camila Nayane de Carvalho Lima, et al.
Mitochondrion (2020) Vol. 57, pp. 23-36
Open Access | Times Cited: 52
Nutrition and bipolar disorder: a systematic review
Fernanda C. Gabriel, Manoela Lima Oliveira, Bruna De Martino Martella, et al.
Nutritional Neuroscience (2022) Vol. 26, Iss. 7, pp. 637-651
Closed Access | Times Cited: 29
Creatine Supplementation in Children and Adolescents
Andrew R. Jagim, Chad M. Kerksick
Nutrients (2021) Vol. 13, Iss. 2, pp. 664-664
Open Access | Times Cited: 33
Role of Creatine Supplementation in Conditions Involving Mitochondrial Dysfunction: A Narrative Review
Robert Percy Marshall, Jan-Niklas Droste, Jürgen Gießing, et al.
Nutrients (2022) Vol. 14, Iss. 3, pp. 529-529
Open Access | Times Cited: 23
The Association Among Bipolar Disorder, Mitochondrial Dysfunction, and Reactive Oxygen Species
Yuki Kageyama, Shohei Okura, Ayaka Sukigara, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 383-383
Open Access
Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine
Sourav Khanra, P. Hemachandra Reddy, Anna Giménez‐Palomo, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 8, pp. 3231-3242
Open Access | Times Cited: 11
Efficacy and safety profile of oral creatine monohydrate in add-on to cognitive-behavioural therapy in depression: An 8-week pilot, double-blind, randomised, placebo-controlled feasibility and exploratory trial in an under-resourced area
Nima Norbu Sherpa, Riccardo De Giorgi, Edoardo G. Ostinelli, et al.
European Neuropsychopharmacology (2024) Vol. 90, pp. 28-35
Open Access | Times Cited: 3
What is bipolar disorder? A disease model of dysregulated energy expenditure
Rodrigo B. Mansur, Yena Lee, Roger S. McIntyre, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 113, pp. 529-545
Closed Access | Times Cited: 21
A Systematic Review of Nutraceuticals for the Treatment of Bipolar Disorder
Melanie M. Ashton, Bianca E. Kavanagh, Wolfgang Marx, et al.
The Canadian Journal of Psychiatry (2020) Vol. 66, Iss. 3, pp. 262-273
Open Access | Times Cited: 18
Mitochondrial modulators in the treatment of bipolar depression: a systematic review and meta-analysis
Liang Liang, Junyu Chen, Ling Xiao, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder
Rodrigo Machado‐Vieira, Alan C. Courtes, Carlos A. Zarate, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 6
The effect of adjunctive nutraceuticals in bipolar disorder: A systematic review of randomized placebo-controlled trials
Laura Fusar‐Poli, Teresa Surace, Antonio Vanella, et al.
Journal of Affective Disorders (2019) Vol. 252, pp. 334-349
Closed Access | Times Cited: 19
Targeting Mitochondrial Dysfunction for Bipolar Disorder
Maya Kuperberg, Sophie Greenebaum, Andrew A. Nierenberg
Current topics in behavioral neurosciences (2020), pp. 61-99
Closed Access | Times Cited: 16
Creatine Supplementation in Children and Adolescents
Andrew R. Jagim, Chad M. Kerksick
(2021)
Open Access | Times Cited: 14
Advances in the psychopharmacotherapy of bipolar disorder type I
Ahmad Sleem, Rif S. El‐Mallakh
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 10, pp. 1267-1290
Closed Access | Times Cited: 13
Diet and Neurocognition in Mood Disorders - An Overview of the Overlooked
Vicent Balanzá‐Martínez, Flávio Shansis, Amparo Tatay-Manteiga, et al.
Current Pharmaceutical Design (2020) Vol. 26, Iss. 20, pp. 2353-2362
Closed Access | Times Cited: 14
Acceptability of dietary or nutritional supplementation in pregnancy (ADONS) – Exploring the consumer's perspective on introducing creatine monohydrate as a pregnancy supplement
Deborah L. de Guingand, Kirsten R. Palmer, Jade Bilardi, et al.
Midwifery (2019) Vol. 82, pp. 102599-102599
Closed Access | Times Cited: 11
Nutraceuticals in mood disorders: current knowledge and future directions
Nikolaj Travica, Scott Teasdale, Wolfgang Marx
Current Opinion in Psychiatry (2022) Vol. 36, Iss. 1, pp. 54-59
Closed Access | Times Cited: 6
The Management of Prodromal Symptoms of Bipolar Disorder: Available Options and Future Perspectives
Elisa Del Favero, C. Montemagni, Paola Bozzatello, et al.
Medicina (2021) Vol. 57, Iss. 6, pp. 545-545
Open Access | Times Cited: 7
New Pharmacological Interventions in Bipolar Disorder
Mário F. Juruena, Luke A. Jelen, Allan H. Young, et al.
Current topics in behavioral neurosciences (2020), pp. 303-324
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top